Opalińska, M., Sowa-Staszczak, A., Grochowska, A., Olearska, H., & Hubalewska-Dydejczyk, A. (2021). Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A.
Chicago Style (17th ed.) CitationOpalińska, Marta, Anna Sowa-Staszczak, Anna Grochowska, Helena Olearska, and Alicja Hubalewska-Dydejczyk. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationOpalińska, Marta, et al. Value of Peptide Receptor Radionuclide Therapy as Neoadjuvant Treatment in the Management of Primary Inoperable Neuroendocrine Tumors. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.